Skip to main content
. 2013 May 21;11(5):1677–1692. doi: 10.3390/md11051677

Figure 3.

Figure 3

Plitidepsin increases the level of phosphorylated JNK in spleens of K562 tumor-bearing mice. Mice xenografted with K562 cells received a single administration of plitidepsin (APL; 200 μg/kg) and either immediately (0 min), or at the indicated times after injection, were sacrificed (5 mice/group). (A) Western blot analysis of total (JNK) and phosphorylated JNK (p-JNK) in spleens excised from the animals. Actin was used as loading control. K, K562 cells; K + APL, plitidepsin-treated K562 cells. (B) Quantification of p-JNK levels (normalized to those of total JNK) at the indicated times after APL administration and related to that of sample vehicle-treated K562 at the indicated times after APL administration. Mean ± SEM values of each group of animals are shown.